{"id":"gelofusine-balanced","safety":{"commonSideEffects":[{"rate":null,"effect":"Allergic reactions / anaphylaxis"},{"rate":null,"effect":"Hyperamylasemia"},{"rate":null,"effect":"Coagulopathy / bleeding complications"},{"rate":null,"effect":"Acute kidney injury"},{"rate":null,"effect":"Hyperkalemia"}]},"_chembl":{"chemblId":"CHEMBL2108518","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Gelofusine balanced is a modified fluid gelatin (succinylated gelatin) solution designed to expand intravascular volume and maintain hemodynamic stability. It functions as a colloid, remaining in the vascular space longer than crystalloid solutions, and is formulated with a balanced electrolyte composition to minimize hyperchloremic acidosis. It is used as a blood substitute or plasma expander in acute blood loss and hypovolemic shock situations.","oneSentence":"Gelofusine balanced is a colloid plasma volume expander that restores and maintains circulating blood volume in hypovolemic patients.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:47:13.764Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hypovolemia and blood loss requiring volume replacement during surgery or trauma"},{"name":"Hypovolemic shock management"}]},"trialDetails":[{"nctId":"NCT07284316","phase":"PHASE2, PHASE3","title":"Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-02-20","conditions":"Cognitive Decline, Subjective Cognitive Impairment, Insulin Resistance","enrollment":100},{"nctId":"NCT07172451","phase":"PHASE4","title":"Gelaspan vs Crystalloid Therapy in Sepsis","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-13","conditions":"Sepsis, Intra-Abdominal Infections","enrollment":318},{"nctId":"NCT02715466","phase":"PHASE4","title":"Gelatin in ICU and Sepsis","status":"TERMINATED","sponsor":"B. Braun Melsungen AG","startDate":"2016-04","conditions":"Hypovolemia","enrollment":167},{"nctId":"NCT04647396","phase":"NA","title":"Biomarker-guided Intervention to Prevent Acute Kidney Injury","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2020-11-17","conditions":"Acute Kidney Injury","enrollment":1180},{"nctId":"NCT06516757","phase":"NA","title":"A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health.","status":"COMPLETED","sponsor":"Love Wellness","startDate":"2024-04-05","conditions":"Vaginal Health, Bacterial Vaginosis","enrollment":40},{"nctId":"NCT05148650","phase":"NA","title":"Impact of Balanced Crystalloid and Colloid Infusion on Haemostasis in Healthy Male Volunteers","status":"UNKNOWN","sponsor":"Medical University of Silesia","startDate":"2021-02-16","conditions":"Perioperative Hemorrhage, Dilutional Coagulopathy","enrollment":25},{"nctId":"NCT03921151","phase":"PHASE1, PHASE2","title":"5HT2CR Balance in Brain Connectivity in Cocaine Dependence","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2014-05-13","conditions":"Cocaine Dependence","enrollment":90},{"nctId":"NCT03190993","phase":"NA","title":"The DEB Pilot Study","status":"COMPLETED","sponsor":"Pennington Biomedical Research Center","startDate":"2017-07-21","conditions":"Nutritional Physiological Phenomena, Obesity","enrollment":20},{"nctId":"NCT03244514","phase":"NA","title":"Biomarker-guided Implementation of the AKI Bundle","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2017-11-02","conditions":"Acute Kidney Injury (Nontraumatic)","enrollment":280},{"nctId":"NCT03869320","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2019-03-25","conditions":"Healthy","enrollment":64},{"nctId":"NCT02632279","phase":"NA","title":"Tryptophan Depletion in PD Patients Treated With STN DBS","status":"TERMINATED","sponsor":"Maastricht University Medical Center","startDate":"2015-11","conditions":"Parkinson's Disease","enrollment":7},{"nctId":"NCT02919319","phase":"PHASE1","title":"A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2015-02-01","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT02808325","phase":"PHASE3","title":"Study on the Efficacy and Safety of Gelaspan","status":"COMPLETED","sponsor":"B. Braun Medical LLC","startDate":"2016-06","conditions":"Hypovolemia","enrollment":72},{"nctId":"NCT00520663","phase":"PHASE1","title":"Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-06-08","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":8},{"nctId":"NCT02782819","phase":"NA","title":"A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2014-09","conditions":"Hypotension and Shock","enrollment":320},{"nctId":"NCT02461329","phase":"NA","title":"Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy","status":"UNKNOWN","sponsor":"Kratochvil Milan, MD","startDate":"2015-05","conditions":"Hemorrhage, Surgical, Hip Replacement, Total, Thrombocytopathy","enrollment":50},{"nctId":"NCT02034682","phase":"NA","title":"The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-01","conditions":"Microvascular Reactivity, Tissue Oxygen Saturation","enrollment":40},{"nctId":"NCT02126956","phase":"PHASE1","title":"Mass Balance, Pharmacokinetics, and Metabolism of 14C-labeled ACT-128800 Administered to Healthy Male Subjects","status":"COMPLETED","sponsor":"Actelion","startDate":"2009-03","conditions":"Pharmacokinetics","enrollment":6},{"nctId":"NCT01515397","phase":"PHASE3","title":"Comparison of Two Gelatine Solutions","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2011-12","conditions":"Hypovolemia","enrollment":40},{"nctId":"NCT01727830","phase":"","title":"Hemodilution and Coagulopathy With 3 Colloids","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2012-06","conditions":"Dilutional Coagulopathy","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Gelofusine balanced","genericName":"Gelofusine balanced","companyName":"B. Braun Melsungen AG","companyId":"b-braun-melsungen-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Gelofusine balanced is a colloid plasma volume expander that restores and maintains circulating blood volume in hypovolemic patients. Used for Acute hypovolemia and blood loss requiring volume replacement during surgery or trauma, Hypovolemic shock management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}